Do effects of sodium–glucose cotransporter-2 inhibitors in patients with diabetes give insight into potential use in non-diabetic kidney disease?
H Rajasekeran, DZ Cherney… - Current Opinion in …, 2017 - journals.lww.com
H Rajasekeran, DZ Cherney, JA Lovshin
Current Opinion in Nephrology and Hypertension, 2017•journals.lww.comDo effects of sodium–glucose cotransporter-2 inhibitors in p... : Current Opinion in Nephrology
and Hypertension Do effects of sodium–glucose cotransporter-2 inhibitors in patients with
diabetes give insight into potential use in non-diabetic kidney disease? : Current Opinion in
Nephrology and Hypertension Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation
Subscribe Register Login Articles & Issues Videos For Authors Journal Info Advanced Search …
and Hypertension Do effects of sodium–glucose cotransporter-2 inhibitors in patients with
diabetes give insight into potential use in non-diabetic kidney disease? : Current Opinion in
Nephrology and Hypertension Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation
Subscribe Register Login Articles & Issues Videos For Authors Journal Info Advanced Search …
Summary
Based on prominent nonglycemic effects, the clinical use of SGLT-2i as renoprotective therapy may extend to nondiabetic chronic kidney diseases subtypes, which could help to address a large, unmet clinical need.
Lippincott Williams & Wilkins